Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Mechanism of Endotoxic Acute Lung Injury-induced Golgi Stress Based on Regulating HO-1/CREB3

NCT06045780 is registered in ClinicalTrials.gov with Tianjin Nankai Hospital as lead sponsor.

NCT NCT06045780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06045780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Mechanism of Endotoxic Acute Lung Injury-induced Golgi Stress Based on Regulating HO-1/CREB3
Lead sponsor
Tianjin Nankai Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 15, 2023
Completion date
November 15, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis